Efficacy News and Research

RSS
NIH awards contract to develop nanotechnology tools for atherosclerosis treatment

NIH awards contract to develop nanotechnology tools for atherosclerosis treatment

Onconova announces agreement with FDA for Estybon- MDS Phase 3 trial

Onconova announces agreement with FDA for Estybon- MDS Phase 3 trial

Australian reimbursement committee is set to consider Novo Nordisk's type 2 diabetes treatment

Australian reimbursement committee is set to consider Novo Nordisk's type 2 diabetes treatment

Depression treatment guidelines updated

Depression treatment guidelines updated

FDA clears DFine's new percutaneous radiofrequency ablation device for metastatic spinal lesions

FDA clears DFine's new percutaneous radiofrequency ablation device for metastatic spinal lesions

J&JPRD receives FDA Complete Response Letter for tapentadol ER tablets NDA

J&JPRD receives FDA Complete Response Letter for tapentadol ER tablets NDA

Onconova enters agreement with FDA for Estybon Phase 3 trial SPA

Onconova enters agreement with FDA for Estybon Phase 3 trial SPA

Agile completes enrollment in AG200-15 Phase 3 contraceptive patch study

Agile completes enrollment in AG200-15 Phase 3 contraceptive patch study

Rate of chemotherapy administration for NSCLC more than twice that reported by SEER

Rate of chemotherapy administration for NSCLC more than twice that reported by SEER

Mandatory ECG screening for athletes

Mandatory ECG screening for athletes

UCI awarded $10M grant to explore ways of preventing staph infections in people harboring MRSA bacteria

UCI awarded $10M grant to explore ways of preventing staph infections in people harboring MRSA bacteria

AVEO Pharmaceuticals to present tivozanib Phase 2 study results at IKCS Symposium

AVEO Pharmaceuticals to present tivozanib Phase 2 study results at IKCS Symposium

CAD usage in screening, diagnostic mammography increases: Study

CAD usage in screening, diagnostic mammography increases: Study

PET imaging technique helps early treatment response assessment for cisplatin-resistant ovarian cancer

PET imaging technique helps early treatment response assessment for cisplatin-resistant ovarian cancer

Study shows no difference between Bevacizumab and Ranibizumab efficacy in treating AMD

Study shows no difference between Bevacizumab and Ranibizumab efficacy in treating AMD

Researchers discover new mechanism of DNA repair process

Researchers discover new mechanism of DNA repair process

Array BioPharma to present positive interim results of Phase 1 ARRY-380 trial at ASCO Symposium

Array BioPharma to present positive interim results of Phase 1 ARRY-380 trial at ASCO Symposium

CEUS ultrasound offers superior efficacy to CT scans

CEUS ultrasound offers superior efficacy to CT scans

Study shows low DRC level may increase risk for non-melanoma skin cancer

Study shows low DRC level may increase risk for non-melanoma skin cancer

Celsion presents Phase I/II DIGNITY trial data at 2010 Breast Cancer Symposium

Celsion presents Phase I/II DIGNITY trial data at 2010 Breast Cancer Symposium

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.